The week-by-week progression shows this pattern clearly
Target: 400600 mcg daily by Weeks 58+
2.3 Test Animals Swiss albino mice ( Mus musculus ) (68 weeks), weighing between 20 and 30 g, were used for the present experiment
The long-term intravenous (IV) application of OHCbl is impracticable for the patients
Keshani M, Alikiaii B, Askari G, Yahyapoor F, Ferns GA, Bagherniya M (2022) The effects of L-carnitine supplementation on inflammatory factors, oxidative stress, and clinical outcomes in patients with sepsis admitted to the intensive care unit (ICU): study protocol for a double blind, randomized, placebo-controlled clinical trial
Taking into account the frequency of alterations in known genes involved in PI3K-AKT-mTOR pathway activation, applying PI3K pathway blockers could possibly be an effective target strategy in MM patients